Sanofi said any further updates on the potential separation from Opella will be provided when a decision is made, according to a press release from the agency.
Headquartered in France, Opella employs more than over 11,000 people and operates in 100 countries and ranks as the world’s third-largest company in the over-the-counter vitamins, minerals and supplements market.
Commonly prescribed medications such as statins, non-steroidal anti-inflammatory drugs and certain blood pressure drugs may significantly delay the onset of…
In recent weeks, biotech companies have faced setbacks in moving forward with clinical trials due to operational delays at the…
Arkansas has become the first state to ban pharmacy benefit managers from owning pharmacies after Gov. Sarah Huckabee Sanders signed…
Comments are closed.
